Insights
Your Data & You: Who Works for Whom?
“The expectations for companies’ use of data analytics go far beyond taking one source of data to create visualizations for a Compliance Committee or Board of Directors.”
– Amy Pawloski, Vice President and General Manager, HelioPDR
Synopsis
Almost every life science company today could likely “check the box” when it comes to having some sort of data analytics aspect of their compliance monitoring program.
The question regulators will start asking companies, however, is no longer “if” a company has adopted data analyses in support of their programs, but rather, “how and to what extent?”
To best safeguard the interests of their organizations, Compliance leaders should be prepared to demonstrate the ways in which their organizations are maximizing the utility of their various data sources to better prevent and deter inappropriate conduct.
Related insights
Top 5 Takeaways from the 2020 Compliance Congress
"You can corrupt a patient, too." - Assistant U.S. Attorney, Chief of Affirmative Civil Enforcement Unit - U.S. Attorney's Office, District of MassachusettsSynopsis On September 21st - 24th, 2020, Informa Connect-CBI hosted its 6th Annual Compliance Congress for...
Modernize & Automate Compliance Monitoring through Digital Tools
"Allowing our customers to be self-sufficient in their compliance auditing is essential to improve efficiency and reduce internal expenses." - John Poulin, Partner and CTO, Helio ArgosSynopsis When Helio Health Group conducted an industry survey, responses indicated...